Poland
# |
Name |
Return on Assets (ROA) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
119.93%
|
Dec. 31, 2023 | USD 1.11 | -3.12% |
|
Poland |
|
2 |
22.41%
|
Sept. 30, 2024 | USD 51.90 | -3.89% |
|
Poland |
|
3 |
19.82%
|
Dec. 31, 2023 | USD 2.23 | -2.59% |
|
Poland |
|
4 |
14.03%
|
Dec. 31, 2023 | USD 34.85 | -3.77% |
|
Poland |
|
5 |
10.98%
|
Dec. 31, 2023 | USD 10.51 | -3.97% |
|
Poland |
|
6 |
3.35%
|
Dec. 31, 2023 | USD 2.81 | -1.43% |
|
Poland |
|
7 |
2.83%
|
Dec. 31, 2023 | USD 206.65 | -0.03% |
|
Poland |
|
8 |
1.79%
|
Dec. 31, 2023 | USD 1.13 | -2.47% |
|
Poland |
|
9 |
1.73%
|
Dec. 31, 2023 | USD 5.23 | -1.43% |
|
Poland |
|
10 |
0.79%
|
Dec. 31, 2023 | USD 3.36 | 11.39% |
|
Poland |
|
11 |
0.28%
|
Dec. 31, 2023 | USD 0.86 | -4.13% |
|
Poland |
|
12 |
-4.94%
|
Dec. 31, 2023 | USD 5.78 | -2.65% |
|
Poland |
|
13 |
-10.66%
|
Dec. 31, 2023 | USD 9.53 | 2.20% |
|
Poland |
|
14 |
-13.53%
|
Dec. 31, 2023 | USD 1.79 | -1.96% |
|
Poland |
|
15 |
-18.51%
|
Dec. 31, 2023 | USD 39.15 | -2.15% |
|
Poland |
|
16 |
-22.85%
|
Dec. 31, 2023 | USD 6.53 | 2.36% |
|
Poland |
|
17 |
-56.43%
|
Dec. 31, 2023 | USD 1.76 | -3.29% |
|
Poland |
|
18 |
-72.55%
|
Dec. 31, 2023 | USD 12.20 | -4.46% |
|
Poland |
|
19 |
-107.48%
|
Dec. 31, 2023 | USD 20.96 | 2.85% |
|
Poland |
The Biotechnology company in Poland with the highest Return on Assets (ROA) is Pharmena S.A. (Warsaw Stock Exchange: PHR.WA) at 119.93%.
The Biotechnology company in Poland with the lowest Return on Assets (ROA) is Bioceltix S.A. (Warsaw Stock Exchange: BCX.WA) at -107.48%.
The top 10 Biotechnology companies in Poland by Return on Assets (ROA) are Pharmena S.A., Synektik Spólka Akcyjna, Mabion S.A., Voxel S.A., Selvita S.A., EMC Instytut Medyczny SA, NEUCA S.A., Synthaverse S.A., Centrum Medyczne ENEL-MED S.A. and BioMaxima S.A..
The bottom 10 Biotechnology companies in Poland by Return on Assets (ROA) are Bioceltix S.A., Captor Therapeutics Spolka Akcyjna, Genomtec S.A., Ryvu Therapeutics S.A., Scope Fluidics S.A., Medinice S.A., Poltreg S.A., Celon Pharma S.A., BIOTON S.A. and BioMaxima S.A..